Literature DB >> 33603161

Quantitative facial phenotyping for Koolen-de Vries and 22q11.2 deletion syndrome.

Alexander J M Dingemans1, Diante E Stremmelaar1, Roos van der Donk1, Lisenka E L M Vissers1, David A Koolen1, Patrick Rump2, Jayne Y Hehir-Kwa3, Bert B A de Vries4.   

Abstract

The Koolen-de Vries syndrome (KdVS) is a multisystem syndrome with variable facial features caused by a 17q21.31 microdeletion or KANSL1 truncating variant. As the facial gestalt of KdVS has resemblance with the gestalt of the 22q11.2 deletion syndrome (22q11.2DS), we assessed whether our previously described hybrid quantitative facial phenotyping algorithm could distinguish between these two syndromes, and whether there is a facial difference between the molecular KdVS subtypes. We applied our algorithm to 2D photographs of 97 patients with KdVS (78 microdeletions, 19 truncating variants (likely) causing KdVS) and 48 patients with 22q11.2DS as well as age, gender and ethnicity matched controls with intellectual disability (n = 145). The facial gestalts of KdVS and 22q11.2DS were both recognisable through significant clustering by the hybrid model, yet different from one another (p = 7.5 × 10-10 and p = 0.0052, respectively). Furthermore, the facial gestalts of KdVS caused by a 17q21.31 microdeletion and KANSL1 truncating variant (likely) causing KdVS were indistinguishable (p = 0.981 and p = 0.130). Further application to three patients with a variant of unknown significance in KANSL1 showed that these faces do not match KdVS. Our data highlight quantitative facial phenotyping not only as a powerful tool to distinguish syndromes with overlapping facial dysmorphisms but also to establish pathogenicity of variants of unknown clinical significance.
© 2021. The Author(s), under exclusive licence to European Society of Human Genetics.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33603161      PMCID: PMC8440607          DOI: 10.1038/s41431-021-00824-x

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   5.351


  17 in total

1.  Clinical and molecular characterization of 17q21.31 microdeletion syndrome in 14 French patients with mental retardation.

Authors:  Christèle Dubourg; Damien Sanlaville; Martine Doco-Fenzy; Cédric Le Caignec; Chantal Missirian; Sylvie Jaillard; Caroline Schluth-Bolard; Emilie Landais; Odile Boute; Nicole Philip; Annick Toutain; Albert David; Patrick Edery; Anne Moncla; Dominique Martin-Coignard; Catherine Vincent-Delorme; Isabelle Mortemousque; Bénédicte Duban-Bedu; Sèverine Drunat; Mylène Beri; Jean Mosser; Sylvie Odent; Véronique David; Joris Andrieux
Journal:  Eur J Med Genet       Date:  2010-11-20       Impact factor: 2.708

2.  Molecular karyotyping in patients with mental retardation using 100K single-nucleotide polymorphism arrays.

Authors:  Juliane Hoyer; Alexander Dreweke; Christian Becker; Ina Göhring; Christian T Thiel; Maarit M Peippo; Ralf Rauch; Michael Hofbeck; Udo Trautmann; Christiane Zweier; Martin Zenker; Ulrike Hüffmeier; Cornelia Kraus; Arif B Ekici; Franz Rüschendorf; Peter Nürnberg; André Reis; Anita Rauch
Journal:  J Med Genet       Date:  2007-06-29       Impact factor: 6.318

3.  A new chromosome 17q21.31 microdeletion syndrome associated with a common inversion polymorphism.

Authors:  David A Koolen; Lisenka E L M Vissers; Rolph Pfundt; Nicole de Leeuw; Samantha J L Knight; Regina Regan; R Frank Kooy; Edwin Reyniers; Corrado Romano; Marco Fichera; Albert Schinzel; Alessandra Baumer; Britt-Marie Anderlid; Jacqueline Schoumans; Nine V Knoers; Ad Geurts van Kessel; Erik A Sistermans; Joris A Veltman; Han G Brunner; Bert B A de Vries
Journal:  Nat Genet       Date:  2006-08-13       Impact factor: 38.330

Review 4.  22q11.2 deletion syndrome.

Authors:  Donna M McDonald-McGinn; Kathleen E Sullivan; Bruno Marino; Nicole Philip; Ann Swillen; Jacob A S Vorstman; Elaine H Zackai; Beverly S Emanuel; Joris R Vermeesch; Bernice E Morrow; Peter J Scambler; Anne S Bassett
Journal:  Nat Rev Dis Primers       Date:  2015-11-19       Impact factor: 52.329

5.  What is new with 22q? An update from the 22q and You Center at the Children's Hospital of Philadelphia.

Authors:  Ian M Campbell; Sarah E Sheppard; T Blaine Crowley; Daniel E McGinn; Alice Bailey; Michael J McGinn; Marta Unolt; Jelle F Homans; Erin Y Chen; Harold I Salmons; J William Gaynor; Elizabeth Goldmuntz; Oksana A Jackson; Lorraine E Katz; Maria R Mascarenhas; Vincent F X Deeney; René M Castelein; Karen B Zur; Lisa Elden; Staci Kallish; Thomas F Kolon; Sarah E Hopkins; Madeline A Chadehumbe; Michele P Lambert; Brian J Forbes; Julie S Moldenhauer; Erica M Schindewolf; Cynthia B Solot; Edward M Moss; Raquel E Gur; Kathleen E Sullivan; Beverly S Emanuel; Elaine H Zackai; Donna M McDonald-McGinn
Journal:  Am J Med Genet A       Date:  2018-10       Impact factor: 2.802

6.  Identifying facial phenotypes of genetic disorders using deep learning.

Authors:  Yaron Gurovich; Yair Hanani; Omri Bar; Guy Nadav; Nicole Fleischer; Dekel Gelbman; Lina Basel-Salmon; Peter M Krawitz; Susanne B Kamphausen; Martin Zenker; Lynne M Bird; Karen W Gripp
Journal:  Nat Med       Date:  2019-01-07       Impact factor: 53.440

7.  Microdeletion encompassing MAPT at chromosome 17q21.3 is associated with developmental delay and learning disability.

Authors:  Charles Shaw-Smith; Alan M Pittman; Lionel Willatt; Howard Martin; Lisa Rickman; Susan Gribble; Rebecca Curley; Sally Cumming; Carolyn Dunn; Dimitrios Kalaitzopoulos; Keith Porter; Elena Prigmore; Ana C V Krepischi-Santos; Monica C Varela; Celia P Koiffmann; Andrew J Lees; Carla Rosenberg; Helen V Firth; Rohan de Silva; Nigel P Carter
Journal:  Nat Genet       Date:  2006-08-13       Impact factor: 38.330

8.  Computer face-matching technology using two-dimensional photographs accurately matches the facial gestalt of unrelated individuals with the same syndromic form of intellectual disability.

Authors:  Tracy Dudding-Byth; Anne Baxter; Elizabeth G Holliday; Anna Hackett; Sheridan O'Donnell; Susan M White; John Attia; Han Brunner; Bert de Vries; David Koolen; Tjitske Kleefstra; Seshika Ratwatte; Carlos Riveros; Steve Brain; Brian C Lovell
Journal:  BMC Biotechnol       Date:  2017-12-19       Impact factor: 2.563

9.  Enabling Global Clinical Collaborations on Identifiable Patient Data: The Minerva Initiative.

Authors:  Christoffer Nellåker; Fowzan S Alkuraya; Gareth Baynam; Raphael A Bernier; Francois P J Bernier; Vanessa Boulanger; Michael Brudno; Han G Brunner; Jill Clayton-Smith; Benjamin Cogné; Hugh J S Dawkins; Bert B A deVries; Sofia Douzgou; Tracy Dudding-Byth; Evan E Eichler; Michael Ferlaino; Karen Fieggen; Helen V Firth; David R FitzPatrick; Dylan Gration; Tudor Groza; Melissa Haendel; Nina Hallowell; Ada Hamosh; Jayne Hehir-Kwa; Marc-Phillip Hitz; Mark Hughes; Usha Kini; Tjitske Kleefstra; R Frank Kooy; Peter Krawitz; Sébastien Küry; Melissa Lees; Gholson J Lyon; Stanislas Lyonnet; Julien L Marcadier; Stephen Meyn; Veronika Moslerová; Juan M Politei; Cathryn C Poulton; F Lucy Raymond; Margot R F Reijnders; Peter N Robinson; Corrado Romano; Catherine M Rose; David C G Sainsbury; Lyn Schofield; Vernon R Sutton; Marek Turnovec; Anke Van Dijck; Hilde Van Esch; Andrew O M Wilkie
Journal:  Front Genet       Date:  2019-07-29       Impact factor: 4.599

10.  Diagnostically relevant facial gestalt information from ordinary photos.

Authors:  Quentin Ferry; Julia Steinberg; Caleb Webber; David R FitzPatrick; Chris P Ponting; Andrew Zisserman; Christoffer Nellåker
Journal:  Elife       Date:  2014-06-24       Impact factor: 8.140

View more
  5 in total

1.  Identification of KANSL1 as a novel pathogenic gene for developmental dysplasia of the hip.

Authors:  Xiaowen Xu; Xinying Bi; Jing Wang; Ronghua Gui; Tengyan Li; Lianyong Li; Binbin Wang
Journal:  J Mol Med (Berl)       Date:  2022-06-21       Impact factor: 5.606

Review 2.  Genomic architecture and functional effects of potential human inversion supergenes.

Authors:  Elena Campoy; Marta Puig; Illya Yakymenko; Jon Lerga-Jaso; Mario Cáceres
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2022-06-13       Impact factor: 6.671

3.  A Case Series of Familial ARID1B Variants Illustrating Variable Expression and Suggestions to Update the ACMG Criteria.

Authors:  Pleuntje J van der Sluijs; Mariëlle Alders; Alexander J M Dingemans; Kareesma Parbhoo; Bregje W van Bon; Jennifer C Dempsey; Dan Doherty; Johan T den Dunnen; Erica H Gerkes; Ilana M Milller; Stephanie Moortgat; Debra S Regier; Claudia A L Ruivenkamp; Betsy Schmalz; Thomas Smol; Kyra E Stuurman; Catherine Vincent-Delorme; Bert B A de Vries; Bekim Sadikovic; Scott E Hickey; Jill A Rosenfeld; Isabelle Maystadt; Gijs W E Santen
Journal:  Genes (Basel)       Date:  2021-08-20       Impact factor: 4.096

4.  Establishing the phenotypic spectrum of ZTTK syndrome by analysis of 52 individuals with variants in SON.

Authors:  Alexander J M Dingemans; Kim M G Truijen; Jung-Hyun Kim; Zahide Alaçam; Laurence Faivre; Kathleen M Collins; Erica H Gerkes; Mieke van Haelst; Ingrid M B H van de Laar; Kristin Lindstrom; Mathilde Nizon; James Pauling; Edyta Heropolitańska-Pliszka; Astrid S Plomp; Caroline Racine; Rani Sachdev; Margje Sinnema; Jon Skranes; Hermine E Veenstra-Knol; Eline A Verberne; Anneke T Vulto-van Silfhout; Marlon E F Wilsterman; Eun-Young Erin Ahn; Bert B A de Vries; Lisenka E L M Vissers
Journal:  Eur J Hum Genet       Date:  2021-09-15       Impact factor: 5.351

5.  Clinical, Immunological, and Genetic Findings in a Cohort of Patients with the DiGeorge Phenotype without 22q11.2 Deletion.

Authors:  Antonino Maria Quintilio Alberio; Annalisa Legitimo; Veronica Bertini; Giampiero I Baroncelli; Giorgio Costagliola; Angelo Valetto; Rita Consolini
Journal:  J Clin Med       Date:  2022-04-05       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.